Session Details

Session Details

12:00 PM - 07:00 PM - Exhibit Hall

Minsung Park - PhD - Charles River Laboratory

867: Closed Automation Enables Quick Fill-Finish of Large-Scale T Cell Therapy While Maintaining Consistency and Quality of the Final Product

12:00 PM - 07:00 PM - Exhibit Hall

Matt Heidtman - Ph.D. - Bio-Techne

868: Efficient T-cell Activation and Expansion for CAR-T Therapy is Dependent on a Complex Interplay of the Starting Donor Population, Activation Antibodies and Expansion Platform

12:00 PM - 07:00 PM - Exhibit Hall

Lindsey Clarke - PhD - MicrofluidX

860: Optimising Lentiviral Transduction Using Microfluidics

12:00 PM - 07:00 PM - Exhibit Hall

Carrie Stoltzman - PhD - Deverra Therapeutics

859: Overcoming Current Challenges in Allogeneic Cell Therapy Manufacturing by Using Pooled Donor Cord Blood CD34+ Cells as Starting Material

12:00 PM - 07:00 PM - Exhibit Hall

Lauren Unsworth - M.Sc. - MaxCyte, Inc.

861: Non-Viral Cell Engineering of Peripheral Blood Natural Killer Cells Using a GMP-Compliant, Scalable Electroporation Platform

12:00 PM - 07:00 PM - Exhibit Hall

Rebecca Warfield - ACROBiosystems

871: Considerations in Raw Materials when Manufacturing Cell Therapies and Other Biologics

12:00 PM - 07:00 PM - Exhibit Hall

Lindsey Clarke - PhD - MFX

870: Impact of Media Exchange Strategy on T-Cell Expansion

12:00 PM - 07:00 PM - Exhibit Hall

Harold Craighead - CyteQuest

866: A Multiplexed and Scalable Continuous-Flow Electroporation Paltform for Efficient Cell Transfection

12:00 PM - 07:00 PM - Exhibit Hall

Abe Wu - University of Washington

869: Aptamer-Based, Traceless Selection of CD62L⁺ CD8⁺ T Cells for Improved Adoptive T Cell Manufacturing

12:00 PM - 07:00 PM - Exhibit Hall

Zachary Imam - PhD - Nanotein Technologies

863: Expansion of Stem-Like T Cells by Protein Nanoscaffold-Based NanoSpark^TM STEM-T Activator

12:00 PM - 07:00 PM - Exhibit Hall

Katrina Adlerz - PhD - CTMC (Cell Therapy Manufacturing Center)

862: Potency Assurance Testing of a CAR-T Cell Therapy Product: Evaluating T Cell Function Using Multiple Quantitative Bioassays

12:00 PM - 07:00 PM - Exhibit Hall

Akshaya Chandrasekaran - Thermo Fisher Scientific

872: Closed Modular Clinical-Scale Manufacturing of CAR T Cells for Cancer Immunotherapy Using Activated and Non-Activated T Cells

12:00 PM - 07:00 PM - Exhibit Hall

Sean Hart - LumaCyte

865: Rapid and Precise Process Monitoring with Label-Free Laser Force Cytology™ Driving Improvements in CGT Manufacturing Quality and Consistency